Previous reports using murine models have shown that TKIs prompt tumor cells to release chemotactic factors (CXCL12 and HMGB-1) or induce immunogenic cell death, resulting in robust immune cell infiltration and tumor clearance [16,41]. This evidence concerns the gene HMGB1 and neoplasm.